Evidence-based monitoring for metabolic syndrome in clients with chronic schizophrenia.
Metabolic syndrome is a risk factor for cardiovascular disease. People with chronic schizophrenia are at risk for metabolic syndrome because of their diets, lifestyle, and (in some cases) their medication. The increased risk of metabolic syndrome has implications for the delivery of care to this population. This article provides an overview of metabolic syndrome in patients with schizophrenia and evidence-based criteria for monitoring this population. A recommendation is made to aggregate data collection in one place to facilitate follow-up. A sample form and letter are provided.
Torres
Deborra M
DM
Ocean Mental Health, Bayville and Toms River, NJ, USA. dtorres903@comcast.net
D014150:Antipsychotic Agents / Q000009:adverse effects; D002908:Chronic Disease; D004032:Diet; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008019:Life Style; D008297:Male; D024821:Metabolic Syndrome / Q000175:diagnosis* / Q000209:etiology; D012307:Risk Factors; D012559:Schizophrenia / Q000150:complications* / Q000188:drug therapy; D014481:United States
D014150:Antipsychotic Agents